OOIR: Observatory of International Research

Papers

(The TQCC of World Psychiatry is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States	444
A meta‐review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders	427
Perinatal mental health: a review of progress and challenges	407
The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality	348
Addressing mental health needs: an integral part of COVID‐19 response	311
Anxiety and depression among general population in China at the peak of the COVID‐19 epidemic	274
Adaptation of evidence‐based suicide prevention strategies during and after the COVID‐19 pandemic	188
Validation of the new DSM‐5‐TR criteria for prolonged grief disorder and the PG‐13‐Revised (PG‐13‐R) scale	188
Preventive psychiatry: a blueprint for improving the mental health of young people	181
The clinical characterization of the adult patient with depression aimed at personalization of management	172
The promise of machine learning in predicting treatment outcomes in psychiatry	172
Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic met	162
Designing and scaling up integrated youth mental health care	162
The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses	160
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors	160
Transdiagnostic clinical staging in youth mental health: a first international consensus statement	153
Assessing the public health impacts of legalizing recreational cannabis use: the US experience	152
The clinical characterization of the patient with primary psychosis aimed at personalization of management	150
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum	145
What is resilience: an affiliative neuroscience approach	144
Psychotherapies for depression: a network meta‐analysis covering efficacy, acceptability and long‐term outcomes of all main treatment types	137
Preventing suicide in the context of the COVID‐19 pandemic	136
Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas	129
Psychiatry in the age of COVID‐19	116
Hierarchical models of psychopathology: empirical support, implications, and remaining issues	106

COVID‐19 and psychiatrists' responsibilities: a WPA position paper	104
An organization‐ and category‐level comparison of diagnostic requirements for mental disorders in ICD‐11 and DSM‐5	99
Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double‐blind randomized controlled trial	99
The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis	98
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021	96
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum	95
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): II. Externalizing superspectrum	93
The relevance of COVID‐19 pandemic to psychiatry	84
“Third‐wave” cognitive and behavioral therapies and the emergence of a process‐based approach to intervention in psychiatry	82
Prioritizing COVID‐19 vaccination for people with severe mental illness	81
Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review	76
Differential impact of COVID‐related lockdown on mental health in Germany	76
Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration	74
Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population‐based cohort study	72
PHQ‐9: global uptake of a depression scale	72
COVID‐19 health anxiety	71
The lived experience of psychosis: a bottom‐up review co‐written by experts by experience and academics	71
Psychological processes mediating the association between developmental trauma and specific psychotic symptoms in adults: a systematic review and meta‐analysis	69
Emerging experience with selected new categories in the ICD‐11: complex PTSD, prolonged grief disorder, gaming disorder, and compulsive sexual behaviour disorder	68
Initial treatment choices to achieve sustained response in major depression: a systematic review and network meta‐analysis	65
A pandemic of social isolation?	64
An update on Individual Placement and Support	64
The unified protocol for transdiagnostic treatment of emotional disorders	62
The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first‐episode psychosis services	61
Mental health care for older adults: recent advances and new directions in clinical practice and research	54
Candidate biomarkers in psychiatric disorders: state of the field	52
Association of preceding psychosis risk states and non‐psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS‐2 cohort	50
Effectiveness of a WHO self‐help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial	50
The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management	50
Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta‐analysis including 409 trials with 52,702 patien	50
The World Mental Health Report: transforming mental health for all	48
The critical distinction between suicidal ideation and suicide attempts	47
Therapist‐supported Internet‐based cognitive behaviour therapy yields similar effects as face‐to‐face therapy for psychiatric and somatic disorders: an updated systematic review and meta‐analysis	47
Hikikomori: a hidden mental health need following the COVID‐19 pandemic	46
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions	46
Mental health problems among COVID‐19 survivors in Wuhan, China	45
Community‐based social interventions for people with severe mental illness: a systematic review and narrative synthesis of recent evidence	45
Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants	44
Brain networks and cognitive impairment in psychiatric disorders	42
Acute psychiatric care: approaches to increasing the range of services and improving access and quality of care	41
New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications	41
Intergenerational psychiatry: a new look at a powerful perspective	40
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents	39
Psychiatric symptoms and cognitive impairment in “Long COVID”: the relevance of immunopsychiatry	38
The p factor is the sum of its parts, for now	38
The emergence of cognitive COVID	38
The impact of social network sites on mental health: distinguishing active from passive use	36
Testing structural models of psychopathology at the genomic level	35
RDoC at 10: changing the discourse for psychopathology	35
Rationale for and usefulness of the inclusion of gaming disorder in the ICD‐11	34

Neurocognitive deficits in schizophrenia are likely to be less severe and less related to the disorder than previously thought	34
The epidemic of fentanyl misuse and overdoses: challenges and strategies	34
Anorexia nervosa and the long‐term risk of mortality in women	34
The importance of listening to patient preferences when making mental health care decisions	33
The evolution of Kraepelin's nosological principles	33
The alliance in mental health care: conceptualization, evidence and clinical applications	31
School mental health: a necessary component of youth mental health policy and plans	30
The clinical characterization of the adult patient with an anxiety or related disorder aimed at personalization of management	30
Setting priority areas for WPA’s new triennium	30
Optimizing personalized management of depression: the importance of real‐world contexts and the need for a new convergence paradigm in mental health	30
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review	29
Racism and mental health	28
Patients with schizophrenia are under‐vaccinated for COVID‐19: a report from Israel	28
The utility of patient‐reported outcome measures in mental health	27
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta‐analysis	27
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction	27
Post‐traumatic stress disorder in the aftermath of COVID‐19 pandemic	26
Estimating the real‐world usage of mobile apps for mental health: development and application of two novel metrics	26
Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort study	26
Thinking too much: rumination and psychopathology	25
Internalizing psychopathology and all‐cause mortality: a comparison of transdiagnostic vs. diagnosis‐based risk prediction	25
Perinatal mental health and the COVID‐19 pandemic	25
COVID‐19 vaccination uptake in people with severe mental illness: a UK‐based cohort study	25
The general factor of psychopathology: a comparison with the general factor of intelligence with respect to magnitude and predictive validity	24
Managing dual disorders: a statement by the Informal Scientific Network, UN Commission on Narcotic Drugs	23
Implementation of the WPA Action Plan 2020‐2023: an update	23
Implementation of the WPA Action Plan 2020‐2023	22
Smartphone relapse prediction in serious mental illness: a pathway towards personalized preventive care	22
WPA Action Plan 2020‐2023: a way forward	22
WPA educational initiatives: where are we after three years?	22
What is global mental health?	21
Dopamine and glutamate in individuals at high risk for psychosis: a meta‐analysis of in vivo imaging findings and their variability compared to controls	21
Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study	20
The network structure of ICD‐11 complex post‐traumatic stress disorder across different traumatic life events	20
A prevalence assessment of prolonged grief disorder in Syrian refugees	20
Alcohol and the developing adolescent brain	20
The role of self‐compassion in psychotherapy	20
Most at‐risk individuals will not develop a mental disorder: the limited predictive strength of risk factors	20
Experimental approaches to social disconnection in the general community: can we learn from schizophrenia research?	19
Rethinking the concept of insight	19
Prenatal mental health and the effects of stress on the foetus and the child. Should psychiatrists look beyond mental disorders?	18
Primary psychosis: more to know, much more to do	18
The application of implementation science to community mental health	18